Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Linaclotide | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Linaclotide | hsa00220 | Arginine biosynthesis | 1.54E-02 | 2 | P05089, P49448 | ARG1, GLUD2 | More | | Linaclotide | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | | Linaclotide | hsa00910 | Nitrogen metabolism | 2.93E-02 | 2 | P22748, P49448 | CA4, GLUD2 | More | | Linaclotide | hsa00983 | Drug metabolism - other enzymes | 3.20E-02 | 3 | P04183, P32320, P05164 | TK1, CDA, MPO | More | | Linaclotide | hsa02010 | ABC transporters | 4.93E-02 | 1 | Q8IZY2 | ABCA7 | More | | Linaclotide | hsa03013 | RNA transport | 3.98E-02 | 9 | P52298, O14893, P61326, Q7Z3B4, P35658, Q14152, O75822, P78345, Q9Y6A5 | NCBP2, GEMIN2, MAGOH, NUP54, NUP214, EIF3A, EIF3J, RPP38, TACC3 | More | | Linaclotide | hsa04060 | Cytokine-cytokine receptor interaction | 5.39E-03 | 10 | P27930, P08476, Q13651, Q9HBE5, Q9UBD3, P47992, P01375, P09341, P18510, Q93038 | IL1R2, INHBA, IL10RA, IL21R, XCL2, XCL1, TNF, CXCL1, IL1RN, TNFRSF25 | More | | Linaclotide | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 4.81E-03 | 9 | P09341, P19875, P25024, P25025, P47992, Q9UBD3, Q13651, P14784, P01375 | CXCL1, CXCL2, CXCR1, CXCR2, XCL1, XCL2, IL10RA, IL2RB, TNF | More | | Linaclotide | hsa04062 | Chemokine signaling pathway | 1.83E-02 | 8 | P25024, P25025, P09341, P19875, P42338, P19174, P63218, P50151 | CXCR1, CXCR2, CXCL1, CXCL2, PIK3CB, PLCG1, GNG5, GNG10 | More | | Linaclotide | hsa04064 | NF-kappa B signaling pathway | 3.68E-04 | 12 | O00463, P14778, P01375, P19174, Q04759, Q16548, P06239, Q13315, P24522, P09341, P19875, Q06643 | TRAF5, IL1R1, TNF, PLCG1, PRKCQ, BCL2A1, LCK, ATM, GADD45A, CXCL1, CXCL2, LTB | More | | Linaclotide | hsa04071 | Sphingolipid signaling pathway | 1.87E-02 | 6 | Q9H228, P01375, Q13362, Q9BX95, Q16539, P10415 | EDG8, TNF, PPP2R5C, SGPP1, MAPK14, BCL2 | More | | Linaclotide | hsa04072 | Phospholipase D signaling pathway | 4.48E-02 | 5 | P42338, P43657, P25024, P25025, P19174 | PIK3CB, P2RY5, CXCR1, CXCR2, PLCG1 | More | | Linaclotide | hsa04146 | Peroxisome | 2.42E-02 | 5 | O43933, P56589, Q9UKG9, O75521, P33121 | PEX1, PEX3, CROT, ECI2, ACSL1 | More | | Linaclotide | hsa04213 | Longevity regulating pathway - multiple species | 3.85E-02 | 4 | P42338, Q9Y4H2, P11142, Q13547 | PIK3CB, IRS2, HSPA8, HDAC1 | More | | Linaclotide | hsa04610 | Complement and coagulation cascades | 2.33E-03 | 1 | P0C0L4 | C4A | More | | Linaclotide | hsa04612 | Antigen processing and presentation | 9.89E-03 | 7 | P13765, P48382, P26715, P26717, Q13241, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, CD8A, TNF | More | | Linaclotide | hsa04613 | Neutrophil extracellular trap formation | 7.32E-03 | 13 | O60603, P05164, P08246, Q9UM07, Q6FI13, Q15080, P20160, P08311, O75015, P21730, P21462, O43315, Q16539 | TLR2, MPO, ELA2, PADI4, H2AC18; H2AC19, NCF4, AZU1, CTSG, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Linaclotide | hsa04640 | Hematopoietic cell lineage | 2.01E-03 | 10 | P14778, P27930, P11215, P25063, P07766, P09693, P01732, P09564, P13765, P01375 | IL1R1, IL1R2, ITGAM, CD24, CD3E, CD3G, CD8A, CD7, HLA-DOB, TNF | More | | Linaclotide | hsa04650 | Natural killer cell mediated cytotoxicity | 2.22E-05 | 11 | P19174, P01375, P06239, O60880, P20963, P42338, Q13241, P26718, O14931, P26717, P26715 | PLCG1, TNF, LCK, SH2D1A, CD247, PIK3CB, KLRD1, KLRK1, NCR3, KLRC2, KLRC1 | More | | Linaclotide | hsa04657 | IL-17 signaling pathway | 2.52E-03 | 7 | O00463, Q16539, P09341, P14780, Q9UJX4, P80188, P01375 | TRAF5, MAPK14, CXCL1, MMP9, ANAPC5, LCN2, TNF | More | | Linaclotide | hsa04658 | Th1 and Th2 cell differentiation | 1.40E-06 | 12 | Q04759, P07766, P20963, P09693, P19174, P06239, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, PLCG1, LCK, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | | Linaclotide | hsa04659 | Th17 cell differentiation | 1.74E-05 | 12 | Q04759, P19174, P06239, P14784, P13765, P14778, Q9HBE5, Q9UL17, P23771, P07766, P09693, P20963 | PRKCQ, PLCG1, LCK, IL2RB, HLA-DOB, IL1R1, IL21R, TBX21, GATA3, CD3E, CD3G, CD247 | More | | Linaclotide | hsa04660 | T cell receptor signaling pathway | 2.81E-05 | 12 | P01375, Q04759, P42338, O95267, Q08881, P19174, P07766, P20963, P09693, P01732, Q13191, P06239 | TNF, PRKCQ, PIK3CB, RASGRP1, ITK, PLCG1, CD3E, CD247, CD3G, CD8A, CBLB, LCK | More | | Linaclotide | hsa04750 | Inflammatory mediator regulation of TRP channels | 7.24E-03 | 5 | P14778, P19174, P42338, P24723, Q04759 | IL1R1, PLCG1, PIK3CB, PRKCH, PRKCQ | More | | Linaclotide | hsa04923 | Regulation of lipolysis in adipocytes | 2.24E-02 | 3 | P07550, P42338, Q9Y4H2 | ADRB2, PIK3CB, IRS2 | More | | Linaclotide | hsa04964 | Proximal tubule bicarbonate reclamation | 2.74E-03 | 3 | P22748, P00918, P49448 | CA4, CA2, GLUD2 | More | | Linaclotide | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | | Linaclotide | hsa04973 | Carbohydrate digestion and absorption | 1.29E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Linaclotide | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.78E-03 | 5 | P09341, P19875, P19174, P25024, P25025 | CXCL1, CXCL2, PLCG1, CXCR1, CXCR2 | More | | Linaclotide | hsa05133 | Pertussis | 4.20E-02 | 1 | P0C0L4 | C4A | More | | Linaclotide | hsa05134 | Legionellosis | 1.29E-02 | 4 | P11215, P11142, P09341, P19875 | ITGAM, HSPA8, CXCL1, CXCL2 | More | | Linaclotide | hsa05143 | African trypanosomiasis | 1.31E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Linaclotide | hsa05144 | Malaria | 3.09E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Linaclotide | hsa05146 | Amoebiasis | 1.01E-05 | 11 | P09341, P19875, P14778, P27930, P01375, P42338, P11215, P05089, P22694, P12814, P08311 | CXCL1, CXCL2, IL1R1, IL1R2, TNF, PIK3CB, ITGAM, ARG1, PRKACB, ACTN1, CTSG | More | | Linaclotide | hsa05202 | Transcriptional misregulation in cancer | 1.84E-04 | 16 | Q15532, Q13315, P41732, P14780, P27930, P14923, Q15744, Q16548, Q13077, O15550, P35226, P05164, P12838, P08246, Q9C0K0, P24522 | SS18, ATM, TSPAN7, MMP9, IL1R2, JUP, CEBPE, BCL2A1, TRAF1, UTX, BMI1, MPO, DEFA4, ELA2, BCL11B, GADD45A | More | | Linaclotide | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.13E-03 | 8 | P42338, O95267, P19174, P07766, P20963, P09693, P06239, Q04759 | PIK3CB, RASGRP1, PLCG1, CD3E, CD247, CD3G, LCK, PRKCQ | More | | Linaclotide | hsa05310 | Asthma | 3.20E-02 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Linaclotide | hsa05321 | Inflammatory bowel disease | 1.25E-03 | 6 | P01375, P13765, Q14765, Q9UL17, P23771, Q9HBE5 | TNF, HLA-DOB, STAT4, TBX21, GATA3, IL21R | More | | Linaclotide | hsa05322 | Systemic lupus erythematosus | 3.90E-02 | 6 | P08246, P08311, P01375, P13765, Q16778, P12814 | ELA2, CTSG, TNF, HLA-DOB, HIST2H2BE, ACTN1 | More | | Linaclotide | hsa05332 | Graft-versus-host disease | 2.55E-02 | 4 | P13765, P01375, P26715, Q13241 | HLA-DOB, TNF, KLRC1, KLRD1 | More | | Linaclotide | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | | |